View:
Bionano Genomics, Inc.
9540 Towne Centre Drive, Suite 100
San Diego, California 92121
(858) 888-7600
August 21, 2020
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey Gabor
|
Re:
|
Bionano Genomics, Inc.
|
|
Registration Statement on Form S-3
|
|
|
File No. 333-245762
|
Ladies and Gentlemen:
Bionano Genomics, Inc. (the “Registrant”)
hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Tuesday, August 25, 2020, or as soon thereafter as
is practicable. The Registrant also hereby requests a copy of the written order verifying the effective date.
If you have any questions regarding this request, please contact James Pennington of Cooley LLP at (858) 550-6029.
Sincerely,
Bionano Genomics, Inc.
|
By:
|
/s/ R. Erik Holmlin, Ph.D.
|
|
|
R. Erik Holmlin, Ph.D.
|
||
|
President and Chief Executive Officer
|
||
|
cc:
|
James Pennington, Cooley LLP
|